Feds Investigating Prescription Drug Price Increases
Nelson has been critical of the $80 billion agreement. In fact, he called for a larger share of savings from the pharmaceutical manufacturers during a Senate Finance Committee hearing in September.
In an amendment, he proposed that the pharmaceutical industry "surrender a financial windfall" it gets on drugs sold to Medicare patients who also qualify for Medicaid, called "dual eligibles." The amendment, which Nelson said would saved taxpayers an estimated $106 billion over 10 years, was based on estimates provided by the Congressional Budget Office. It was defeated in a 13-10 vote at that time.
Janice Simmons is a senior editor and Washington, DC, correspondent for HealthLeaders Media Online. She can be reached at email@example.com.
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- Doctors Feel Pressure to Accept Risk-based Reimbursement
- Roundtable: To Arrest HAIs, Culture Trumps Campaigns
- Wanted: Nurse PhDs
- 4 Tectonic Shifts Shaking Up Healthcare
- Slideshow: Healthcare Leaders Name IT Spending Priorities
- A Fresh Look at End-of-Life Care
- 3 in 4 Patients Want E-mail Consultations
- New Orleans East Hospital opens quietly, still seeking accreditation
- CVS Ramps Up Retail Clinics with Provider Affiliations